Label Changes for:

Singulair (montelukast sodium) Tablets, Chewable Tablets, and Oral Granules

December 2011

Changes have been made to the ADVERSE REACTIONS and PATIENT PACKAGE INSERT sections of the safety label.

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) – December 2011

 

 

ADVERSE REACTIONS

Postmarketing Experience
  • erythema multiforme

 

PATIENT PACKAGE INSERT

Other side effects with Singulair include
  • severe skin reactions (erythema multiforme) that may occur without warning
Hide
(web3)